Tag: Vaccines
Johnson & Johnson Makes $1 Billion Vaccine Deal
Company has said it will offer doses at a not-for-profit cost to provide global access to the vaccine
Experimental COVID-19 Vaccine Shows Encouraging Results
One study revealed that 56 people made high levels of antibodies with no adverse side effects
U.S. Puts Up Another $2.1 Billion for Potential COVID-19 Vaccine
GlaxoSmithKline and Sanofi Pasteur will supply 100 million doses of its experimental vaccine to the U.S.
Plenty of COVID-19 Vaccine Coming, Fauci Says
To combat the surging pandemic, Fauci is calling on all Americans to practice social distancing and wearing masks
Teen HPV Vaccination Rates Suboptimal
Half of parents of unvaccinated teens have no intention to initiate the vaccine series
Nirsevimab Injection Cuts RSV-Linked Infections in Preemies
Maternal RSV fusion protein nanoparticle vaccine did not meet prespecified success criterion for efficacy
2008 to 2018 Saw Increase in Shingles Vaccination in Over 60s
Women equally as likely as men to have received vaccine; coverage highest for non-poor, those with higher education
American Cancer Society Updates HPV Vaccination Guidelines
Vaccination should be routinely offered at age 9 to 12 years; catch-up vaccination recommended through age 26
Company Gets $1.6 Billion From U.S. Government for COVID-19 Vaccine
Novavax has never brought a product to market before
Promising Results for Experimental COVID-19 Vaccine in Early Testing
Preliminary findings show that 45 study volunteers who received either a low or medium dose had immune response
